Poolbeg Pharma’s Jeremy Skillington talks to Proactive London after signing a deal with CytoReason, a leading artificial intelligence (AI) to provide AI analysis of Poolbegโ€™s influenza disease progression data derived from human challenge study samples.

Watch the video here.